Denise Scots-Knight - Chief Executive Officer, Director at Mereo BioPharma Group plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
MREO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Denise Scots-Knight - trading volume in the past year for Mereo BioPharma Group plc

Holdings reported by Denise Scots-Knight for Mereo BioPharma Group plc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
American Depositary Shares representing Ordinary Shares 809K $3.41M $4.22 Sep 13, 2024 Direct
Share Options (Right to buy) 850K $859K $1.01 Jan 25, 2024 Direct American Depository Shares
Performance Based Restricted Stock Unit 0 Sep 11, 2024 Direct American Depository Shares

Transactions reported by Denise Scots-Knight for Mereo BioPharma Group plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.